Why is Nidan Laborator. falling/rising?

As of 20-Aug, Nidan Laboratories & Healthcare Ltd is currently priced at 19.25, reflecting an increase of 0.15 or 0.79%. Despite this slight uptick, the stock has shown a significant decline over the past year, with a return of -42.28%. Today's price summary indicates that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 185.71% compared to the 5-day average. The company's return on capital employed (ROCE) stands at 3.4, indicating an attractive valuation, but its profits have decreased by 40% over the past year, contributing to the stock's overall poor performance. In the broader market context, the stock's short-term return of +1.58% over the past week is slightly below the benchmark Sensex, which has increased by 1.75%. This underperformance is consistent with the stock's long-term trend, where it has consistently lagged behind the benchmark over the last three years. The company's weak long-term fundamental strength, highlighted by its inability to declare results in the last six months and a poor EBIT to interest ratio of 1.75, further exacerbates investor concerns. Overall, while there is a minor uptick in the stock price, the underlying fundamentals and historical performance suggest a challenging outlook for Nidan Laboratories & Healthcare Ltd.